Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Suppressor cell function in multiple sclerosis: correlation with clinical disease activity.

J P Antel, B G Arnason, M E Medof

    Annals of Neurology
    |April 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    α7 nicotinic acetylcholine receptor signaling modulates the inflammatory phenotype of fetal brain microglia: first evidence of interference by iron homeostasis.

    Scientific reports·2017
    Same author

    RNAseq profiling of primary microglia and astrocyte cultures in near-term ovine fetus: A glial in vivo-in vitro multi-hit paradigm in large mammalian brain.

    Journal of neuroscience methods·2016
    Same author

    Strategy for anti-aquaporin-4 auto-antibody identification and quantification using a new cell-based assay.

    Clinical immunology (Orlando, Fla.)·2010
    Same author

    Glatiramer acetate-reactive T lymphocytes regulate oligodendrocyte progenitor cell number in vitro: role of IGF-2.

    Journal of neuroimmunology·2010
    Same author

    TLR-mediated B cell activation results in ectopic CLIP expression that promotes B cell-dependent inflammation.

    Journal of leukocyte biology·2010
    Same author

    Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells.

    Glia·2007

    Multiple sclerosis (MS) patients with active disease exhibit significantly reduced Concanavalin A (Con A)-activated suppressor cell activity. This impaired immune regulation may correlate with disease activity and immune complex levels in MS.

    Area of Science:

    • Immunology
    • Neuroscience
    • Cell Biology

    Background:

    • Multiple Sclerosis (MS) is a chronic inflammatory disease of the central nervous system.
    • Immune dysregulation, particularly involving suppressor cells, is implicated in MS pathogenesis.
    • Understanding suppressor cell function is crucial for developing targeted therapies for MS.

    Purpose of the Study:

    • To investigate Concanavalin A (Con A)-activated suppressor cell activity in multiple sclerosis (MS) patients with varying disease states.
    • To assess the correlation between suppressor cell activity, disease activity, and immune complex levels in MS.
    • To evaluate the in vitro effect of Levamisole on suppressor cell activity in MS.

    Main Methods:

    • Concanavalin A (Con A) activation of peripheral blood lymphocytes from MS patients and controls.

    Related Experiment Videos

  • Measurement of suppressor cell activity by inhibition of autologous lymphocyte mitogenic response.
  • Assay of suppressor factors using supernatants from activated cells and their effect on L cell proliferation.
  • Quantification of immune complexes using the Raji cell technique.

    • Main Results:

    • Reduced Con A-activated suppressor cell activity was observed in active MS patients (3%) compared to stable MS patients (30%), recovering MS patients (62%), and controls (40%).
    • Supernatant-mediated inhibition of L cell proliferation was lower in active and stable MS patients (7%) versus controls (21%).
    • Elevated immune complex levels were noted in three of four active MS patients with low suppressor activity; Levamisole did not alter suppressor cell activity in vitro.

    Conclusions:

    • Con A-activated suppressor cell activity is significantly diminished in active multiple sclerosis.
    • Impaired suppressor cell function and elevated immune complexes may contribute to MS pathogenesis.
    • Further research is warranted to explore the therapeutic potential of modulating suppressor cell activity in MS.